Robert I. Haddad, MD, is an associate professor of medicine at Harvard Medical School, and is Disease Center Leader of the Head and Neck Oncology Program and a member of the Department of Adult Oncology at the Dana-Farber Cancer Institute in Boston, Massachusetts. Dr Haddad’s research activities involve the use of induction chemotherapy for patients with locally advanced head and neck cancer and the development of novel immunotherapeutic agents for treating locally advanced disease. He is a member or several professional societies, and has been instrumental in the development, execution and publication of numerous phase II and III trials in head and neck cancer. Dr Haddad received his medical degree from St. Joseph University French School of Medicine in Beirut.